April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
COMPARISON OF CLINICAL OUTCOMES BETWEEN 27-GAUGE TRANSCONJUNCTIVAL NONVITRECTOMIZING VITREOUS SURGERY AND 25-GAUGE VITRECTOMY IN PATIENTS WITH EPIRETINAL MEMBRANE
Author Affiliations & Notes
  • Cesare Mariotti
    Clinica Oculistica, Universita Politecnica delle Marche, Ancona, Italy
  • Francesca Viti
    Clinica Oculistica, Universita Politecnica delle Marche, Ancona, Italy
  • Andrea Saitta
    Clinica Oculistica, Universita Politecnica delle Marche, Ancona, Italy
  • Michele Nicolai
    Clinica Oculistica, Universita Politecnica delle Marche, Ancona, Italy
  • Salvatore Faro
    Ophthalmology, University of Catania, Catania, Italy
  • Emanuele Orsini
    Clinica Oculistica, Universita Politecnica delle Marche, Ancona, Italy
  • Livio Giulio Marco Franco
    Ophthalmology, University of Catania, Catania, Italy
  • Caterina Gagliano
    Ophthalmology, University of Catania, Catania, Italy
  • Santo Stella
    Ophthalmology, University of Catania, Catania, Italy
  • Michele Reibaldi
    Ophthalmology, University of Catania, Catania, Italy
  • Footnotes
    Commercial Relationships Cesare Mariotti, None; Francesca Viti, None; Andrea Saitta, None; Michele Nicolai, None; Salvatore Faro, None; Emanuele Orsini, None; Livio Giulio Marco Franco, None; Caterina Gagliano, None; Santo Stella, None; Michele Reibaldi, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2296. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Cesare Mariotti, Francesca Viti, Andrea Saitta, Michele Nicolai, Salvatore Faro, Emanuele Orsini, Livio Giulio Marco Franco, Caterina Gagliano, Santo Stella, Michele Reibaldi; COMPARISON OF CLINICAL OUTCOMES BETWEEN 27-GAUGE TRANSCONJUNCTIVAL NONVITRECTOMIZING VITREOUS SURGERY AND 25-GAUGE VITRECTOMY IN PATIENTS WITH EPIRETINAL MEMBRANE. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2296.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare the clinical outcomes and the rate of complications between 27-gauge transconjunctival nonvitrectomizing vitreous surgery (NVS) and 25-gauge transconjunctival sutureless vitrectomy surgery for idiopathic epiretinal membrane (ERM) removal.

Methods: In this retrospective, comparative study, all consecutive phakic patients with an idiopathic ERM, that underwent 25-gauge standard vitrectomy (Standard-group), or 27-gauge NVS (NVS group), between May 2010 and January 2012, with a minimal follow-up of 12 months, were evaluated. Main outcome measures were best-corrected visual acuity (BCVA), optical coherence tomography (OCT) changes, and nuclear sclerotic cataract progression, at 6 months and 12 months after surgery.

Results: Mean logarithm of the minimal angle of resolution BCVA improved significantly at all time points (P < .01,Tukey-Kramer test), in the standard group from 0.43 to 0.24 at 12 months and in the NVS group from 0.46 to 0.16, without significant difference between the 2 groups. Compared with baseline, at 6 and 12 months after treatment, central foveal thickness decreased significantly in both groups (P < .01,Tukey-Kramer test), with no significant difference between the 2 groups at any time point. At 12 months eyes undergoing standard vitrectomy surgery developed significantly more nuclear light scatter than in the lens of the NVS-group ones (79 % vs 12 %; P < .001, chi-square). At 12 months, the ERM recurred in 4% of eyes in the Standard-group and in 14% of eyes in the NVS-group, without significant difference between the 2 groups.

Conclusions: The 27-gauge NVS is an effective method as vitrectomy in the treatment of ERM, with less progression of cataract.

Keywords: 762 vitreoretinal surgery  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×